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INTRODUCTION
Atrial fibrillation (AF) increases the risk of cardio-embolic 
stroke [1]. Patients with AF in sinus rhythm (SR) are also 
characterised by a hypercoagulable state [2], which is fur-
ther augmented by a coexisting inflammatory response [3]. 
The prothrombotic state in AF is associated with increased 
thrombin formation, higher von Willebrand factor (vWF), 
and increased plasminogen activator inhibitor-1 (PAI-1), with 
altered fibrin clot properties [2, 3]. Hypercoagulability has 
been shown to be linked with left atrial (LA) remodelling and 
wall stress [4]. In patients without documented AF, the LA ap-
pendage thrombus was associated with prothrombotic blood 
alterations [5]. Elevated levels of proinflammatory interleukin 6 
(Il-6) and C-reactive protein were associated with increased 
thromboembolic risk in AF patients [3].
Previous studies have provided conflicting evidence 
regarding haemostasis and inflammatory status in response 
to rapid atrial pacing [6, 7]. It is likely that a hypercoagulable 
state and inflammation may be at least partially dependent 
on the tachyarrhythmia that is associated with AF, emphasising 
the importance of rate control [6]. 
Pulmonary vein isolation (PVI) is a beneficial procedure 
to manage the symptoms in patients with AF [8]. It has been 
documented that the LA scarring associated with PVI increases 
the risk of cerebral embolism [9]. The mechanism of this as-
sociation has not been fully elucidated.
We sought to evaluate the LA and peripheral haemostasis, 
fibrinolysis, and inflammatory response in patients with AF 
during a PVI procedure and following an episode of rapid 
atrial pacing.
METHODS
A total of 14 patients with either paroxysmal or persistent 
AF, referred for PVI, were enrolled in this preliminary, 
prospective, observational study. All patients gave their 
written, informed consent to participate. The study was ap-
proved by the local Ethics Committee and complied with 
the principles of the Declaration of Helsinki. The exclusion 
criteria were lack of adequate anticoagulation in the month 
preceding the procedure, prior ischaemic or haemorrhagic 
stroke, venous or arterial thromboembolism, estimated glo-
merular filtration rate < 60 mL/min/1.73 m2, pregnancy, and 
age < 18 and > 80 years. 
Blood samples were obtained at the beginning of the 
PVI procedure (from the peripheral vein [PV]), and during 
the PVI procedure: LA1 — immediately after the interatrial 
septum puncture, prior to heparin administration; LA2 — at 
least 5 min after the administration of an unfractionated 
heparin IV bolus (100 IU/kg) with activated clotting time 
(ACT) of > 300 s, before the application of radiofrequency 
(RF) energy; and LA3 — after successful isolation of all pul-
monary veins. The patients who were in SR underwent rapid 
atrial pacing at the rate of 150 bpm prior to the application of 
RF energy. The interval between rapid atrial pacing and the 
ablation was 20 min.
We determined plasma vWF using a latex immunoassay 
(Diagnostica Stago, Asnières, France), whereas soluble P-selec-
tin and Il-6 (R&D Systems, Minneapolis, MN, USA) as well as 
tissue plasminogen activator (tPA) antigen and PAI-1 antigen 
(American Diagnostica, Stamford, CT, USA) were determined 
using enzyme-linked immunosorbent assays (ELISA).
www.kardiologiapolska.pl
Atrial fibrillation: inflammation and fibrinolysis
387
All patients received vitamin K antagonists (VKA) for at 
least one month prior to PVI. PVI was preceded by tran-
soesophageal echocardiography within 24 h before the 
procedure. LA rotational angiography was performed at 
the beginning of the procedure. Following the transseptal 
puncture, three-dimensional electro-anatomical mapping was 
performed using the CARTO3® system (Biosense Webster, Dia-
mond Bar, CA, USA) in patients undergoing RF ablation with 
a ThermoCool® SmartTouch® SF catheter (Biosense Webster).
In patients who were in SR during the procedure, the abla-
tion was preceded by a 5-min episode of rapid atrial pacing at 
150 bpm in order to compensate for the lack of arrhythmia. The 
interval between pacing and PVI in these patients was 20 min.
The procedure was performed with an international 
normalised ratio (INR) of up to 2.5 (preferably 2.0–2.5). All 
patients received unfractionated heparin (IV bolus 100 IU/kg) 
immediately after the transseptal puncture and a continuous 
infusion of 2000 IU/h through the transseptal sheath to obtain 
an ACT over 300 s, measured at 30-min intervals during the 
procedure. A postprocedural 24-h heparin infusion under ACT 
control was continued in patients with an INR < 2.0 during 
the procedure. The next VKA dose was administered 4 h after 
the procedure to obtain an INR within the range of 2.0–3.0 on 
the following day.
Statistical analysis
The statistical analysis was performed using the MedCalc 
v.14.8.1 (MedCalc Software, Ostend, Belgium). Distribution 
of variables was verified using the Shapiro-Wilk test. Temporal 
variations of the biomarker concentration were evaluated us-
ing Wilcoxon matched pairs test for dependent samples and 
Friedman analysis of variance (ANOVA). A p-value < 0.05 was 
considered statistically significant.
RESULTS AND DISCUSSION
We studied 14 symptomatic AF patients at a mean age of 
57.5 (43–64) years (men 57.1%) with a high prevalence 
of arterial hypertension (n = 12, 85.7%), hyperlipidaemia 
(n = 10, 71.4%), and coronary artery disease (n = 4, 28.6%). 
All patients had a normal left ventricular ejection fraction 
(LVEF: 55%, interquartile range: 50%–60%). Paroxysmal AF 
was diagnosed in six (42.9%) patients, and PVI was performed 
in this sub-group while the patients remained in SR. The 
CHA2DS2-VASc score was 2 (1–3) points.
Tissue plasminogen activator antigen concentration 
was higher (6.81 [5.81–7.98] vs. 5.76 [4.76–6.71] ng/mL, 
p = 0.002, respectively), while PAI-1 levels tended to 
be higher (15.1 [12.0–17.3] vs. 13.0 [10.3–16.5] ng/mL, 
p = 0.090, respectively) in the LA than in the PV. Plasma vWF 
(p = 0.23), soluble P-selectin (p = 1.00), and Il-6 (p = 0.157) 
were similar in the venous and LA samples. 
A serial biomarker sampling during the procedure re-
vealed that the Il-6 levels gradually increased after the trans-
septal puncture (LA1 vs. LA2) and even more (LA2 vs. LA3) 
after PVI (Table 1). Although tPA and PAI-1 levels did not 
change significantly after the transseptal puncture, AF abla-
tion led to a marked increase in both biomarkers, while vWF 
and soluble P-selectin concentrations remained unchanged 
in all samples (Table 1).
Patients who had had PVI performed in AF were charac-
terised by higher tPA in LA (LA2: 7.9 [6.9–8.7] vs. 5.8 [5.7–
–6.7] ng/mL, p = 0.008) and a lower vWF concentration 
(LA2: 200.0 [191.0–207.5] vs. 219.5 [213.0–236.0] IU/dL, 
p = 0.014) compared to those in SR before PVI. There were 
no differences in terms of PAI-1 levels at LA1 (p = 0.401) 
and LA2 (p = 0.175), but PAI-1 level at LA3 tended to be 
higher in patients ablated in AF compared with those in SR 
(17.9 [16.4–20.4] vs. 15.6 [14.9–16.2] ng/mL, p = 0.081). 
Il-6 remained comparable between the preprocedural SR 
and AF groups.
The present study suggests enhanced inflammation 
secondary to mechanical manipulation during transseptal 
puncture, which was further potentiated by application of 
RF energy, and impaired fibrinolysis secondary to ablation. 
Table 1. Comparison of the biomarker concentrations in the left atrium at different time points during ablation
Variables LA1* LA2* LA3* P** P***
LA1 vs. LA2 LA1 vs. LA3 LA2 vs. LA3
vWF [IU/dL] 198.0 (188.0–210.0) 209.5 (199.0–220.0) 200.5 (187.0–212.0) 0.490 0.778 0.300 0.395
sPs [ng/mL] 100.5 (94.0–111.0) 106.0 (98.0–112.0) 91.5 (83.0–111.0) 0.490 0.152 0.149 0.458
IL-6 [pg/mL] 11.3 (8.6–11.9) 12.7 (10.5–13.9) 14.2 (12.0–15.4) 0.011 0.001 0.001 0.0001
tPA [ng/mL] 6.81 (5.81–7.98) 6.99 (5.87–8.06) 11.3 (10.3–13.3) 0.826 0.001 0.001 < 0.0001
PAI-1 [ng/mL] 15.1 (12.0–17.3) 14.2 (11.5–16.0) 16.5 (15.6–18.5) 0.754 0.084 0.011 0.008
*Data are presented as median and one and three quartile boundaries (1–3Q); **Wilcoxon matched pairs test; ***Friedman analysis of variance 
(ANOVA); Il-6 — interleukin 6; LA1 — blood withdrawn immediately after the interatrial septum puncture, prior to heparin administration;  
LA2 — blood withdrawn ≥ 5 min or after the administration of an unfractionated heparin IV bolus (100 IU/kg) with activated clotting time of  
> 300 s, before application of radiofrequency energy; LA3 — blood withdrawn after successful isolation of all pulmonary veins; in patients in 
sinus rhythm at baseline, the ablation was preceded by a 5-min episode of rapid atrial pacing at 150 bpm; PAI-1 — plasminogen activator  
inhibitor-1; sPs — soluble P-selectin; tPA — tissue plasminogen activator antigen; vWF — von Willebrand factor
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Although the presence of AF during the procedure is associ-
ated with increased tPA antigen, it does not lead to platelet 
activation, reflected by soluble P-selectin or the inflammatory 
response as shown by Il-6. The relative increase of tPA and 
decrease of vWF antigen, both of which are mainly released 
from endothelial cells, may reflect complex alterations to 
markers of endothelial injury during an active AF episode.
Our results are in line with findings in an animal model, 
suggesting that local inflammation, reflected by tumour 
necrosis factor alpha (TNF-a) and Il-6, might be induced by 
a prolonged rapid atrial pacing [7]. Although Lim et al. [6] cor-
roborated that both AF and rapid atrial pacing at 150 bpm led 
to LA platelet activation (P-selectin elevation) and increased 
thrombin generation, previous reports did not show elevated 
PAI-1 antigen following an episode of induced high atrial rate, 
suggesting PAI-1–driven impaired fibrinolysis in this setting. 
The major study limitation is the LA3 sample acquisition, 
because changes in Il-6 and PAI-1 could be triggered by both 
RF ablation and rapid atrial pacing in patients who were in 
SR at baseline. The study represented a preliminary report of 
a larger investigation, in which blood was acquired from LA at 
four time points, including an additional LA blood acquisition 
after rapid atrial pacing and prior to ablation. Unfortunately, in 
this study we measured biomarkers only at three time points, 
hence at LA3 the biomarkers were measured after ablation 
(persistent AF) or after rapid atrial pacing and subsequent 
ablation (paroxysmal AF patients only with SR at the beginning 
of the procedure). Presumably, rapid atrial pacing performed 
20 min before the initiation of ablation had a minor impact 
on PAI-1 decrease and Il-6 increase, which was primarily 
mediated by ablation-related endocardial injury. Ideally, two 
sample acquisitions: (1) after rapid atrial pacing, and (2) after 
application of RF energy should be performed. Still, these data 
lay the foundation for the notion that PVI is related to inflam-
mation and impaired fibrinolysis, presumably translating into 
increased risk of periprocedural thrombotic complications.
In conclusion, the current preliminary results suggest that 
initial mechanical LA manipulation and PVI itself preceded by 
rapid atrial pacing are associated with a pronounced inflam-
matory response, while RF ablation and rapid atrial pacing 
seem to be associated with impaired fibrinolysis. Larger studies 
are needed to confirm these observations.
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